Dermipsor is a clinical-stage drug development company focusing on novel therapies for the dermatology market. Dermipsor’s products offer more effective and safer solutions for patients suffering from psoriasis, atopic dermatitis and other skin conditions.

Exceptional Speed: Dermipsor's advanced clinical pipeline was created in record time, and the company expects to bring its products to the market as early as 2011

Exceptional Novelty: Innovative strategies for developing much needed therapies for skin diseases

Exceptional Safety: Dermipsor understands that safety is of paramount importance to dermatology patients and focuses on developing efficacious drugs with a superior safety profile